2003후1550
According to Korean Supreme Court Decision No. 2003HU1550 (December 23, 2004), since a use of a medicine of a specific substance is essential in a medicinal use invention, the claims of the invention must clearly describe the medicinal use of the specific material in terms of the to-be-treated diseases or pharmacological effects. In addition, the above judicial precedent stated the following regarding the description requirements for the detailed description of a patent application:
The detailed description of the specification attached to a patent application must clearly describe the object, constitution and working effect of an invention in such a manner that a person skilled in the art can clearly understand and reproduce the invention without any special knowledge in view of the state of the art at the time of filing the patent application. In particular, the requirements for the specification are met and the invention is considered as being complete only if a use invention of a medicine requiring pharmacological effects describes examples showing pharmacological data of a specific substance or is described so specifically as to replace such examples, unless the pharmacological mechanism of the pharmacological effects are well known before the filing of the patent application.
The detailed description of the specification attached to a patent application must clearly describe the object, constitution and working effect of an invention in such a manner that a person skilled in the art can clearly understand and reproduce the invention without any special knowledge in view of the state of the art at the time of filing the patent application. In particular, the requirements for the specification are met and the invention is considered as being complete only if a use invention of a medicine requiring pharmacological effects describes examples showing pharmacological data of a specific substance or is described so specifically as to replace such examples, unless the pharmacological mechanism of the pharmacological effects are well known before the filing of the patent application.